Amorepacific vs LG H&H, the Rivalry Behind Your Shelf
Pick up five different Korean skincare bottles at random and there is a good chance that most of them, maybe all of them, come from one of exactly two companies. Not two brands, two entire corporations, each one owning a stack of names you probably already recognize without knowing they are related at all. Sulwhasoo and Laneige answer to the same parent as Innisfree and, more recently, COSRX. The History of Whoo and Belif answer to a completely different one, alongside CNP and The Face Shop. Once you know this, shopping for Korean beauty starts to look less like picking individual products and more like picking a side in a rivalry that has quietly shaped the entire industry for decades.
This is not a story you will find printed on a single label, because neither company particularly wants you thinking about ownership structures while you are trying to decide between a fermented essence and a snail mucin serum. But once you see the pattern, it changes how you read every ingredient list, every price tag, and every marketing campaign that comes out of Korea.
 |
| Almost everything on a K-beauty shelf traces back to one of two Korean companies. |
Amorepacific built its identity on heritage, then bought its way into the future
Amorepacific has been around since 1945, and its oldest, most prestige brands still lean hard into that history. Sulwhasoo is the clearest example, built entirely around hanbang, the traditional Korean herbal medicine philosophy, using ginseng and other botanical ingredients fermented and processed the way Korean apothecaries have done it for generations. The brand does not just mention hanbang in passing, it structures its entire research language around it, right down to how it names ingredient complexes after traditional medicine terms.
Laneige and Innisfree took that same research base and made it more accessible, softer price points, brighter packaging, water-focused formulas that feel younger and less ceremonial than Sulwhasoo. But the underlying research culture never really changed. Fermentation technology, in particular, is something Amorepacific treats almost like a signature move, using it to break ingredients down into forms the skin absorbs more easily than the raw extract ever could. If you have ever wondered why so many Korean essences smell faintly of rice wine or something slightly earthy, fermentation is usually the reason.
What makes Amorepacific interesting right now is what it did in 2023, when it took a 93.2 percent controlling stake in COSRX, a brand that built its entire following on Amazon reviews, TikTok challenges, and a very different kind of marketing than anything Amorepacific had done before. COSRX did not get folded into some legacy formula the way you might expect from an acquisition. It kept operating with its own hypoallergenic, ingredient-forward approach, snail mucin, salicylic acid, centella asiatica, and Amorepacific mostly stayed out of the way while feeding it manufacturing scale and research resources instead. That deal tells you a lot about Amorepacific's real strategy right now. Keep the heritage brands doing heritage things, and buy your way into whatever the internet is already obsessed with, rather than trying to build that same digital-native energy from scratch.
The acquisition has paid off in a very tangible way. COSRX continued expanding into new markets under Amorepacific's ownership, and its skincare lines kept showing up on bestseller lists in the United States, Southeast Asia, and Europe, all while Amorepacific's older luxury brands like Sulwhasoo kept doing their own thing on a completely separate track. Two very different audiences, two very different price points, one shared parent company quietly benefiting from both.
LG H&H plays a different game, luxury at the top and tech underneath
LG H&H, founded two years earlier in 1947, tells a different story. Its flagship prestige line, The History of Whoo, sells almost entirely on the idea of royal Korean court beauty rituals, gold accents, ornate bottles, ginseng and herbal complexes with names borrowed from Joseon dynasty medicine texts, and a price point that sits noticeably above most of Amorepacific's premium tier. Where Sulwhasoo whispers heritage through minimalist packaging and understated marketing, The History of Whoo performs it, loudly and without apology, which is exactly why it has become one of the best-selling luxury beauty exports out of Korea, particularly in the Chinese market where that kind of ornate storytelling resonates strongly with shoppers.
Below that luxury tier, LG H&H's portfolio gets a lot more functional and a lot less ceremonial. Belif leans into apothecary-style, ingredient-transparent formulas built around single hero botanicals rather than elaborate blends. CNP focuses on dermatology-adjacent skincare that reads more like something a skin clinic would stock than something a department store counter would push. The Face Shop covers the accessible, everyday mass market, the kind of brand you grab when your skin needs something simple and affordable that still actually works.
 |
| Knowing which company owns a brand tells you a surprising amount about how it was formulated. |
In 2025, LG H&H picked up LG Electronics' beauty device brand Pra.L, and that move says something meaningful about where the company thinks skincare is heading. Not just serums and creams anymore, but devices meant to work alongside them at home, the kind of at-home facial tools that used to require a trip to a dermatologist's office. LG H&H has also been investing in AI-assisted ingredient discovery through its parent group's research arm, using a model built to identify promising new cosmetic compounds in roughly a day instead of the nearly two years that kind of research traditionally takes. Whether that timeline holds up perfectly in practice is almost beside the point. What it signals is a company betting on technology and research speed as its long-term edge, rather than trying to out-heritage Amorepacific at its own game of centuries-old herbal formulas.
Two very different recent report cards
These are not equally healthy companies right now, and that difference is genuinely worth knowing before anyone assumes bigger always means better, or that both companies are running the same playbook with different logos slapped on the front. LG H&H's beauty division went through a rough stretch through most of 2025, with sales and operating profit both sliding as competition intensified at home and its push into North America, built partly around acquiring existing Western brands like The Crème Shop and Avon rather than leading with its own Korean identity, struggled to gain the traction analysts had expected. There is something almost counterintuitive about a Korean beauty company trying to grow in America by buying American brands instead of exporting its own, and that strategy has drawn real criticism for potentially diluting exactly the kind of K-beauty appeal that should have been its biggest advantage.
Amorepacific, over roughly that same period, kept posting steadier growth, helped along significantly by COSRX's continued momentum overseas and by its established luxury names holding their ground in China and other key export markets. It has not been a flawless run for Amorepacific either, but the contrast between the two companies' recent earnings reports has been sharp enough that beauty industry trade press has covered it as its own storyline.
LG H&H brought in a new beauty division CEO in late 2025, someone with a background at L'Oréal Korea working on Kiehl's and later leading the North American expansion of the sheet mask brand Mediheal, and the early results in the first quarter of 2026 suggest the beauty unit is stabilizing again, turning a modest profit after several difficult quarters. None of this means one company's actual products are objectively better formulated than the other's, that is a separate conversation entirely about ingredients and results. It means the two companies are currently running genuinely different playbooks. One is leaning on a controlling stake in a digitally native brand that was already working before it was acquired. The other is betting on a leadership change, a slower rebuild around its luxury core, and a longer-term wager on device technology and AI-assisted formulation.
 |
| Choosing a brand is really choosing which research priorities and philosophy you want on your skin. |
What this actually means for what ends up in your cart
None of this corporate history is trivia for its own sake, and it changes how you shop in some genuinely useful ways once you start paying attention to it. A Sulwhasoo purchase and a Laneige purchase are both, in a real sense, investments in the same fermentation and hanbang research pipeline, just packaged at different price points and different levels of polish for different moments in your routine. A COSRX purchase is an investment in a completely different philosophy, minimal ingredient lists, dermatologist-style simplicity, active ingredients dosed for visible results rather than ritual, that happens to share a parent company with the more traditional, ceremonial side of the same portfolio.
On the other side of the rivalry, choosing The History of Whoo means buying into ornate, ritual-forward luxury skincare with a price tag to match its ambitions, ginseng complexes with centuries of storytelling behind them, gold-flecked packaging designed to feel like an heirloom. Choosing Belif or CNP instead means buying into a far more clinical, ingredient-first approach from the exact same corporate family, stripped of the theater but built on a lot of the same underlying research capability.
There is also a practical shopping angle worth mentioning here. Because both conglomerates own such a wide spread of price points, from drugstore to luxury, you can often trace a specific active ingredient or formulation technique down through several tiers of the same company's portfolio. A fermentation technique that debuted in a Sulwhasoo serum costing well over a hundred dollars sometimes trickles down into a Laneige or even an Innisfree formula within a year or two, at a fraction of the price, simply because the underlying research and manufacturing capacity already exists inside the same corporate family. The same pattern shows up on the LG H&H side, where innovations tested in The History of Whoo's premium lines eventually influence more accessible formulas under Belif or CNP.
Once you see the shelf this way, the choice between brands stops being about which bottle looks nicer sitting on your bathroom counter, and starts being about which research philosophy you actually want to support with your money. Fermented, heritage-driven, and quietly modernizing through smart acquisitions, or luxury-forward, tech-curious, and currently in the middle of an ambitious rebuild. Either direction leads to genuinely good skincare, but knowing which company is actually behind the bottle in your hand makes every future purchase a slightly more informed one, and that is a far more interesting way to shop than most beauty guides ever bother to explain.
Data Sources
PRNewswire, Amorepacific corporate release on COSRX stake acquisition, 2023
Personal Care Insights, LG H&H beauty division earnings and strategy reporting, 2025 to 2026
Cosmetics Design Asia, LG H&H Q2 2025 financial results reporting, 2025
Explore more Insights into Korean Lifestyle:
- beauty / K-beauty hair / kbeauty / Korean hair care / scalp careJun 28, 2026
- beauty / K-beauty Seoul / kbeauty / personal color analysis / Seoul beauty experienceJun 28, 2026
- beauty / kbeauty / Korean makeup trend / lingerie makeup / skin makeupJun 28, 2026
.webp)
.webp)
.webp)
.webp)
.webp)
.webp)
.webp&description=Amorepacific vs LG H&H, the Rivalry Behind Your Shelf){kind=link}
0 Comments